Topazium selected as a contributor in the Biogen Accelerator

This exclusive initiative, spearheaded by Biogen (https://www.biogen.com/) and HLTH Inc. (https://hlth.com/), aims to accelerate innovation in the field of rare neuromuscular diseases, with a strong focus on early diagnosis and patient engagement. Topazium, selected from hundreds of applicants after a rigorous three-month evaluation process, is one of five companies chosen to bring AI-driven solutions to…

NutriGuard™ selected finalist for the Best Health Data Driven Innovation Award at DES#2023

NutriGuard™, Topazium’s AI tool to harness the healthy benefits of food, has been selected as a finalist for the Awards category: BEST HEALTH DATA-DRIVEN INNOVATION at #DES2023*! NutriGuard™ purpose is to promote and preserve health by using deep learning techniques applied to different sources of information. On the one hand, it takes all available information about…

Globant and Topazium Announce Partnership to Deliver AI-Powered End-to-End Solutions to the Life Sciences Industry

Globant and Topazium join to create new paradigms in drug discovery, clinical research, diagnostics, and well-being MADRID – September 27, 2022 – Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, and Topazium, the biotech startup specialized in integrating the latest advances in artificial intelligence (AI) with traditional medical…